A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
Public ClinicalTrials.gov record NCT07201051. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Investigate Efficacy, Safety, Immunogenicity, and Pharmacokinetics, of GSK3862995B in Participants With Bronchiectasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to find out how effective and safe a new drug, GSK3862995B, is for adult participants with bronchiectasis, a chronic lung disease. The study will also test how the body processes the drug and to check for any immune reactions. Participants will be divided into groups randomly to receive either one of two different doses of the study drug or a placebo. The main goal of the study is to see how well the drug works compared to the placebo in helping those with bronchiectasis.
Study identification
- NCT ID
- NCT07201051
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 363 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 29, 2025
- Primary completion
- May 3, 2027
- Completion
- Dec 9, 2027
- Last update posted
- Aug 11, 2026
2025 – 2027
United States locations
- U.S. sites
- 31
- U.S. states
- 17
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Mobile | Alabama | 36608 | Recruiting |
| GSK Investigational Site | Phoenix | Arizona | 85027 | Recruiting |
| GSK Investigational Site | La Palma | California | 90623 | Recruiting |
| GSK Investigational Site | Valencia | California | 91355 | Recruiting |
| GSK Investigational Site | Aurora | Colorado | 80012 | Recruiting |
| GSK Investigational Site | Miami | Florida | 33126 | Recruiting |
| GSK Investigational Site | Miami | Florida | 33176 | Recruiting |
| GSK Investigational Site | Naples | Florida | 34102 | Recruiting |
| GSK Investigational Site | Pembroke Pines | Florida | 33029 | Recruiting |
| GSK Investigational Site | Plantation | Florida | 33324 | Recruiting |
| GSK Investigational Site | St. Petersburg | Florida | 33707 | Recruiting |
| GSK Investigational Site | Tamarac | Florida | 33321 | Recruiting |
| GSK Investigational Site | Winter Park | Florida | 32789 | Recruiting |
| GSK Investigational Site | Hammond | Indiana | 46324 | Recruiting |
| GSK Investigational Site | New Orleans | Louisiana | 70112 | Recruiting |
| GSK Investigational Site | Rockville | Maryland | 20854 | Recruiting |
| GSK Investigational Site | St Louis | Missouri | 63110 | Recruiting |
| GSK Investigational Site | Henderson | Nevada | 89052 | Recruiting |
| GSK Investigational Site | New Hyde Park | New York | 11040 | Recruiting |
| GSK Investigational Site | Winston-Salem | North Carolina | 27103 | Recruiting |
| GSK Investigational Site | DuBois | Pennsylvania | 15801 | Recruiting |
| GSK Investigational Site | Anderson | South Carolina | 29621 | Recruiting |
| GSK Investigational Site | Rock Hill | South Carolina | 29732 | Recruiting |
| GSK Investigational Site | Spartanburg | South Carolina | 29303 | Recruiting |
| GSK Investigational Site | Union | South Carolina | 29379 | Recruiting |
| GSK Investigational Site | Franklin | Tennessee | 37067 | Recruiting |
| GSK Investigational Site | Knoxville | Tennessee | 37919 | Recruiting |
| GSK Investigational Site | Conroe | Texas | 77384 | Recruiting |
| GSK Investigational Site | Cypress | Texas | 77429 | Recruiting |
| GSK Investigational Site | Sugar Land | Texas | 77479 | Recruiting |
| GSK Investigational Site | Williamsburg | Virginia | 23188 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 103 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07201051, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07201051 live on ClinicalTrials.gov.